Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Chinese Patent Office
Dow
Deloitte
QuintilesIMS
US Army
Cantor Fitzgerald
Boehringer Ingelheim

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020184

« Back to Dashboard

NDA 020184 describes ACEON, which is a drug marketed by Symplmed Pharms Llc and is included in one NDA. It is available from one supplier. Additional details are available on the ACEON profile page.

The generic ingredient in ACEON is perindopril erbumine. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the perindopril erbumine profile page.
Summary for 020184
Tradename:ACEON
Applicant:Symplmed Pharms Llc
Ingredient:perindopril erbumine
Patents:0
Therapeutic Class:Cardiovascular Agents
Pharmacology for NDA: 020184
Medical Subject Heading (MeSH) Categories for 020184
Suppliers and Packaging for NDA: 020184
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACEON perindopril erbumine TABLET;ORAL 020184 NDA Lannett Company, Inc. 0527-1919 N 0527-1919-01
ACEON perindopril erbumine TABLET;ORAL 020184 NDA Lannett Company, Inc. 0527-1920 N 0527-1920-01

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Dec 30, 1993TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Dec 30, 1993TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength8MG
Approval Date:Dec 30, 1993TE:RLD:Yes

Expired US Patents for NDA 020184

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-002 Dec 30, 1993 ➤ Sign Up ➤ Sign Up
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-002 Dec 30, 1993 ➤ Sign Up ➤ Sign Up
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-001 Dec 30, 1993 ➤ Sign Up ➤ Sign Up
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-003 Dec 30, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Chinese Patent Office
Cerilliant
Johnson and Johnson
Fuji
Boehringer Ingelheim
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.